A $1 device delivers naked mRNA vaccines as effectively as lipid nanoparticles in mice and human skin

Key Findings

Your RNA drug might not replicate — and codon choice is why 🧬

• Self-amplifying RNA vaccines need to do two things: translate a protein AND copy themselves. Researchers found that multiple therapeutic genes failed the second step entirely — not because the backbone was broken, but because the gene's codon composition was wrong.
• Rewriting the same genes with higher GC content (above 53%) and lower dinucleotide density rescued replication. Deliberately degrading a working gene's composition killed it again, confirming the effect is causal.

Pulmonary mRNA vaccine primes immune cells in days, then holds protection for weeks 🫁

• A single windpipe-delivered mRNA-lipid nanoparticle dose in female mice triggered two distinct immune waves: within 1–7 days, lung neutrophils and macrophages shifted into a pre-activated, bacteria-killing state — no antigen recognition needed. Weeks later, a full adaptive response kicked in.
• The vaccine protected against both lab strains and drug-resistant clinical isolates of Pseudomonas aeruginosa, a pathogen with few good vaccine options.

mRNA vaccines can quiet autoimmunity — even without "immune-silent" carriers 🛡️

• The prevailing assumption in autoimmune vaccine design is that you need specially engineered, inflammation-free lipid nanoparticles to induce tolerance. This study challenged that: standard immunostimulatory nanoparticles carrying a myelin protein fragment still reduced disease severity in a multiple sclerosis mouse model.
• Adding mRNA encoding immune-regulatory molecules (a modified version of IL-2 and a chemokine) on top of the autoantigen improved outcomes further, suggesting antigen identity — not carrier quietness — is the dominant variable.

An mRNA contrast agent lets MRI see brain tumors — and tell them apart from treatment scars 🧠

• Distinguishing a growing glioma from pseudoprogression (treatment-related brain changes that look like tumor growth) is one of neuro-oncology's most persistent headaches. Researchers engineered an mRNA that encodes a water channel protein, delivered via a serotonin-derived lipid nanoparticle, to boost MRI signal specifically in tumor tissue.
• A modified regulatory region in the mRNA ensures the protein is only produced in glioma cells, not healthy brain — making the contrast agent self-selective without a targeting antibody.

A peptide nanoparticle keeps mRNA expression alive for 7 days — lipid nanoparticles fade in 48 hours ⏱️

• A three-peptide delivery system for SARS-CoV-2 spike mRNA stayed at the injection site and drained into lymph nodes, while lipid nanoparticles pooled in the liver. mRNA expression lasted up to 7 days versus under 48 hours for lipid nanoparticles.
• The prolonged antigen exposure drove neutralizing antibody levels comparable to lipid nanoparticles, but with significantly stronger CD8+ T cell responses — the arm of immunity most relevant to killing infected cells.

Africa's mRNA manufacturing push: real progress, real gaps 🌍

• A policy-focused paper maps where African nations stand on building domestic mRNA vaccine production: human capacity and technical training have advanced meaningfully, but regulatory infrastructure and supply chain independence remain incomplete.
• The authors frame this not as a distant goal but as an active public health strategy — the COVID-19 pandemic exposed the cost of continent-wide dependence on external vaccine supply in real time.